AI assistant
HARVARD BIOSCIENCE INC — Director's Dealing 2025
Mar 21, 2025
34975_dirs_2025-03-21_dba50d9f-4171-4345-a3e5-12c05d3fe55b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: HARVARD BIOSCIENCE INC (HBIO)
CIK: 0001123494
Period of Report: 2025-03-19
Reporting Person: Green James W (Director, Chief Executive Officer)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-03-19 | Common Stock | F | 38413 | $0.6886 | Disposed | 2845088 | Direct |
Footnotes
F1: The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with restricted stock unit ("RSU") awards previously granted to the Reporting Person that vested on March 19, 2025.
F2: Includes (a) 117,713 RSUs that will vest on December 29, 2025, (b) 143,198 RSUs that will vest in two equal installments on March 19, 2026 and 2027, (c) 554,407 RSUs with performance based vesting conditions and (d) 2,029,770 shares of common stock beneficially owned by the Reporting Person.